A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Biopharma’s recent string of CEO splits
Biopharma’s recent string of CEO splits
Cancer tests are becoming more precise and guiding pharma R&D
Cancer tests are becoming more precise and guiding pharma R&D
What 3 recent FDA rejections reveal about shifts inside the agency
What 3 recent FDA rejections reveal about shifts inside the agency
Inside the race to thwart the dramatic rise in early-onset colorectal cancer
Inside the race to thwart the dramatic rise in early-onset colorectal cancer
J&J’s blockbuster Spravato is setting the stage for managing psychedelics’ risks
J&J’s blockbuster Spravato is setting the stage for managing psychedelics’ risks
Big Pharma’s next entrant could come from China
Big Pharma’s next entrant could come from China
How PBM reforms could push drugmakers into the pricing spotlight
How PBM reforms could push drugmakers into the pricing spotlight
Biohaven says FDA roadblocks leave rare disease patients in limbo
Biohaven says FDA roadblocks leave rare disease patients in limbo
China’s biopharma advance draws financial investment
China’s biopharma advance draws financial investment
Will the FDA yank mRNA vaccines?
Will the FDA yank mRNA vaccines?
How does the FDA really feel about psychedelics? We could soon find out.
How does the FDA really feel about psychedelics? We could soon find out.
Operating a new standard for life-saving pharmaceutical logistics
Operating a new standard for life-saving pharmaceutical logistics
No one-trick pony in oncology, Merck’s cancer footprint is expanding
No one-trick pony in oncology, Merck’s cancer footprint is expanding
Will vaccine regulatory uncertainty chill innovation? Pharma execs sound off.
Will vaccine regulatory uncertainty chill innovation? Pharma execs sound off.
Pharma could be on the cusp of finally breaking the blood-brain barrier
Pharma could be on the cusp of finally breaking the blood-brain barrier
AI is slashing jobs across industries. Will pharma be next?
AI is slashing jobs across industries. Will pharma be next?
More drugmakers are turning to cancer combos. Will it help patients live longer?
More drugmakers are turning to cancer combos. Will it help patients live longer?
Sanofi, looking for more ‘rigor,’ swaps CEO Hudson for ex-Merck KGaA chief
Sanofi, looking for more ‘rigor,’ swaps CEO Hudson for ex-Merck KGaA chief
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page